vaginal ring eluting etonogestrel and ethinyl estradiol

  • abnormal uterine bleeding
  • dysmenorrhea
  • menorrhagia
  • polycystic ovarian syndrome
drug interactions
or cautions
  • breast cancer or other estrogen- or progestin-dependent neoplasms, women at high risk of arterial or venous thrombotic diseases
  • migraine with aura, uncontrolled hypertension, women >35 years of age who smoke, inherited/acquired coagulopathies
Drug interactions
  • anticonvulsants, antibiotics, benzodiazepines, barbiturates, antihistamines, analgesics
Adverse Effects
(common and severe)
  • headache
  • vaginitis
  • leukorrhea
  • acne
  • breast tenderness
  • nausea
Instructions and dose
(initial; typical)
one ring, inserted vaginally and left in place for 3 consecutive weeks, then removed for 1 week. new ring inserted 7 days after the last was removed.
  • blood pressure
Source of Suggestion
Commonly prescribed medication (Added on March, 2016)